Health in Cuba 999 indicators covering health for Cuba. IndicatorLatest Year10-yr change Rank Private health expenditure per person 427.06 2023 up 59.5% 91st Public healthcare spending share gdp 7.83 2023 down 14.4% 18th Health spending per person by source 2,148 2023 up 12.3% 45th Share of public expenditure on healthcare by country 83.39 2023 down 4.8% 15th Poliomyelitis - number of reported cases 0 2018 — 8th Number of new hiv infections per year 1,801 2024 down 16.2% 59th Rubella vaccination coverage 99 2024 unchanged 1st Deaths from aids un 383.86 2024 up 13.9% 67th Mortality rate among children ages 10 to 14 years 0.9908 2020 down 6.8% 127th Terrorism deaths by region 0 2021 — 58th Medical doctors 94,066 2022 up 14.6% 30th Adults (ages 15-49) newly infected with HIV 1,700 2024 down 15.0% 54th People with basic handwashing facilities including soap and water 93.4% 2024 up 9.6% 27th Number of new hiv child infections vs number of infections averted due 45.07 2024 up 66.6% 61st Mean systolic blood pressure 117.6 2015 down 1.3% 172nd UHC Service Coverage sub-index on infectious diseases 94 2023 up 6.8% 88th UHC Service Coverage sub-index on service capacity and access 99 2023 down 1.0% 4th UHC Service Coverage sub-index on reproductive, maternal, newborn and 86 2023 down 4.4% 25th UHC Service Coverage Index 86 2023 up 3.6% 12th UHC Service Coverage sub-index on noncommunicable diseases 69 2023 up 11.3% 44th Stillbirth rate 8.99 2023 up 41.9% 88th Number of stillbirths 871 2023 up 8.3% 101st Hepb3 number unvaccinated 957.44 2023 down 81.3% 148th Rotavirus vaccines completed dose (RotaC) immunization coverage among 0.0% 2025 — 138th Young people (ages 15-24) newly infected with HIV 530 2024 down 19.7% 52nd Tb related deaths hiv 16 2023 up 23.1% 108th Smoking bans in public places 4 2022 unchanged 115th Current health expenditure (CHE) as percentage of gross domestic produ 9.4% 2023 down 10.0% 38th External health expenditure (EXT) as percentage of current health expe 0.0% 2023 down 80.7% 137th Domestic general government health expenditure (GGHE-D) as percentage 83.4% 2023 down 4.8% 15th Out-of-pocket expenditure as percentage of current health expenditure 16.6% 2023 up 35.1% 137th Domestic general government health expenditure (GGHE-D) as percentage 7.8% 2023 down 14.4% 17th Domestic general government health expenditure (GGHE-D) as percentage 20.0% 2023 up 41.3% 10th Domestic private health expenditure (PVT-D) as percentage of current h 16.6% 2023 up 35.1% 164th Health expenditure government expenditure 19.98 2023 up 41.3% 10th Current health expenditure (CHE) per capita in US$ 1,199 2020 up 97.1% 59th Domestic private health expenditure (PVT-D) per capita in US$ 106.98 2020 up 91.5% 112th Domestic general government health expenditure (GGHE-D) per capita in 1,092 2020 up 97.6% 47th Total healthcare expenditure gdp 9.38 2023 down 10.0% 38th Mumps - number of reported cases 0 2025 — 110th Incidence of tuberculosis (per 100 000 population) 0.61 2023 down 7.6% 112th Hib vaccine 99 2024 up 2.1% 1st Congenital Rubella Syndrome - number of reported cases 0 2025 — 16th External health expenditure (EXT) per capita in US$ 0.6674 2020 up 178.4% 133rd Dentists 17,657 2022 up 26.1% 29th People with basic handwashing facilities including soap and water, rur 88.1% 2024 up 15.8% 24th Nursing and midwifery personnel 79,569 2022 down 13.6% 56th Nursing personnel 79,569 2022 down 13.6% 54th Raised blood pressure (SBP>=140 OR DBP>=90) 26.85 2019 down 3.6% 134th Raised blood pressure (SBP>=140 OR DBP>=90) 29.34 2019 up 2.3% 105th Hypertension: diagnosis coverage among adults aged 30-79 with hyperten 70.1% 2019 up 5.7% 19th Hypertension among adults aged 30-79 years, prevalence, age-standardiz 39.9 2019 up 3.4% 79th Hypertension effective treatment coverage (controlled hypertension )am 32.8% 2019 up 17.6% 24th Hypertension: effective treatment coverage (controlled hypertension) a 33.9% 2019 up 21.1% 23rd Hypertension treatment coverage among adults aged 30-79 with hypertens 63.1% 2019 up 10.3% 16th Hypertension treatment coverage among adults aged 30-79 with hypertens 60.6% 2019 up 6.9% 16th Hypertension: diagnosis coverage among adults aged 30-79 with hyperten 72.1% 2019 up 8.1% 22nd Hypertension among adults aged 30-79 years, prevalence, crude 44.4 2019 up 11.6% 39th Pneumococcal conjugate second or third-dose vaccines (PCVc) immunizati 99.0% 2025 — 1st People with basic handwashing facilities including soap and water, urb 94.9% 2024 up 8.0% 22nd ← Previous Page 10 of 17 Next →